MGAT5 and inflammatory bowel disease: This evidence supporting the link between MGAT5 glycogene and ILC3 modulation was further validated in clinical samples obtained from mucosal biopsies of CD and UC patients, as well as healthy individuals (controls) (Supplementary Table S1).Accordingly, the results showed that inflamed biopsies from IBD patients displayed a significant decreased frequency of ILC3 compared to healthy controls (Figure 6(e)).